Ask most people what air pollution does to the body and they will point to their chest. Asthma. Coughing. Lung cancer. The images that accompany news stories about smog show people in masks, as if the danger stopped at the airway.
The World Health Organization’s own breakdown tells a different story. Of the deaths it attributes to outdoor air pollution, 68 per cent are from heart disease and stroke. Chronic obstructive pulmonary disease accounts for 14 per cent, acute lower respiratory infections for 14 per cent, and lung cancer for 4 per cent.
In other words, the burden of dirty air sits mostly in cardiology and neurology wards, not respiratory clinics. And because the patients there are recorded as having heart attacks and strokes, not “pollution disease,” the cause largely disappears from view.
A burden hidden by the way we count
The headline numbers are large enough on their own. The WHO estimates that the combined effects of outdoor and household air pollution are associated with 6.7 million premature deaths a year. The State of Global Air 2024 report, produced by the Health Effects Institute with the Institute for Health Metrics and Evaluation, put the total at 8.1 million deaths in 2021, making air pollution the second leading risk factor for death worldwide. The two estimates differ in method and reference year, but both describe one of the largest avoidable causes of death on the planet.
And the WHO reports that 99 per cent of the world’s population in 2019 lived in places where its air quality guideline levels were not met.
Yet almost no one dies “of” air pollution on a death certificate. The exposure is diffuse, chronic and shared by everyone in a city. It raises risk slightly for millions of people rather than dramatically for a few. That is precisely the kind of risk that clinical medicine, organised around individual patients and specific diagnoses, is worst at seeing.
The list keeps getting longer
The cardiovascular link is only the best-established part of the story. The 2024 Lancet Commission on dementia included air pollution among its 14 modifiable risk factors for dementia, alongside familiar ones like hypertension and smoking. The research base on links to other chronic conditions continues to grow.
Why the heart, not just the lungs
The mechanism is less mysterious than the public framing suggests. Fine particles do not stay politely in the airways. They set off inflammation and oxidative stress that spill into the bloodstream, stiffen arteries, nudge blood pressure upward, make blood more prone to clot and disturb the nervous control of heart rhythm. The smallest particles and some of their chemical passengers appear to cross into the circulation directly. None of this requires a dramatic dose. It works the way high cholesterol works: quietly, over years, loading the dice for an event that eventually arrives with a different name on it.
That also explains why the burden falls hardest on people who are already sick. A healthy thirty-year-old breathing a bad week of air mostly feels scratchy. A seventy-year-old with coronary disease and a fragile plaque is closer to the edge, and a bad week is enough to tip some of them over. Epidemiologists see this as spikes in cardiac admissions after pollution episodes; clinicians see individual heart attacks with no obvious trigger.
Each addition to the list makes the same point. Air pollution is not a niche environmental topic. It is a risk factor that acts across the major noncommunicable diseases that health systems already spend most of their money treating.
The incentive problem: the benefits land in the wrong ministry
If clean air saves so many lives, why is it so hard to get?
Because the costs and benefits land in different places. The costs of cleaner air fall on energy, transport, industry and households, which must switch fuels, upgrade vehicles, retrofit plants or change how they heat their homes and cook. The benefits appear years later as fewer heart attacks, strokes and hospital admissions, in the budget of the health ministry, which usually has no say in any of those decisions.
Health professionals also tend to treat air pollution as outside their lane. A cardiologist will counsel a patient on smoking, cholesterol and blood pressure, but rarely on the air in their neighbourhood or kitchen, partly because there is little the individual patient can do about it.
There is a timing problem layered on top. A transport minister who tightens diesel rules faces angry hauliers this year. The avoided heart attacks arrive over the following decade, spread thinly across hospitals, invisible in any single year’s statistics and credited to nobody. Politics discounts that kind of benefit heavily. Tobacco control overcame the same structure only once health professionals made the victims visible and named an industry responsible. Air pollution has no single industry to name, which makes the job harder, not optional.
A back-of-envelope for a health minister
Put the WHO split into a budget conversation. Take a hypothetical country where the standard estimates attribute 50,000 deaths a year to outdoor air pollution. Using the WHO proportions, about 34,000 of those would be heart disease and stroke, 7,000 COPD, 7,000 lower respiratory infections and 2,000 lung cancer. The cardiovascular share alone is larger than the other three combined, more than eight times the lung cancer share.
Now remember that deaths are the tip. Every fatal heart attack or stroke sits on top of a larger pile of non-fatal ones: ambulance runs, cath-lab time, rehabilitation, lifelong medication, carers who leave work. The health ministry pays for all of it. What it rarely does is attribute any of it to the air, so it never appears as a line item that a cleaner-air policy could shrink. A ministry that can say “roughly two-thirds of our pollution burden walks through the cardiology door” has a very different conversation with the finance and energy ministries than one talking about wheezing children, sympathetic as that image is.
The figure is illustrative, not a forecast for any real country. The logic is the point: the arithmetic of attribution turns an environmental externality into a health-budget pressure, and budget pressures are what ministries actually negotiate over.
The strongest objection
The best counterargument is that attribution estimates are models, not counts. They depend on exposure-response curves, on assumptions about how risk behaves at very high concentrations, and on satellite-derived exposure data that can be patchy. The WHO and State of Global Air figures differ by more than a million deaths, which tells you how much judgement sits inside them. A sceptical finance official can reasonably ask why a health ministry’s case should rest on numbers with such wide bands.
This objection partly holds. Nobody should present a single point estimate as if it were a mortality register. But the uncertainty is about size, not direction. Across methods, the cardiovascular share dominates, and the evidence that falling pollution is followed by falling cardiovascular risk comes from many settings, not one model. Uncertain costs are also how every other preventive policy is appraised. Tobacco control was not delayed until each smoking death could be individually certified.
The second objection is subtler: that cardiologists wading into energy policy will be seen as partisan and lose authority. That risk is real, which is why the useful clinical voice is the specific one (“this is what I see in my ward after a smog week”) rather than a general call to arms.
The encouraging evidence comes from places that treated air quality as a political priority rather than a technical side issue.
China is the most dramatic example. In 2014, Premier Li Keqiang declared a “war against pollution.” According to the University of Chicago’s Air Quality Life Index, particulate pollution in China fell by about 41 per cent between 2014 and 2023. The AQLI estimates that if the reductions are sustained, the average person in China can expect to live around two years longer than in 2013.
The details of China’s approach, including its heavy-handed enforcement, are not easily transferable. But the lesson is: pollution levels that seemed like a permanent feature of economic development turned out to respond to policy within a decade.
The second-order lesson is about attribution again. When China’s air improved, nobody sent a thank-you note to the energy regulators from a stroke unit. Gains in cardiovascular outcomes get credited to statins, better emergency care and blood pressure programmes, which all deserve some of it. If the health sector does not track the share owed to cleaner air, it will not defend that policy when an industry lobby argues for relaxing it.
What each actor can actually do
The health sector cannot build power plants or rewrite transport policy. It can stop treating air pollution as someone else’s problem, and the jobs differ by seat.
Health ministries should put air pollution burden estimates into national noncommunicable disease plans next to tobacco and hypertension, with the cardiovascular share stated plainly. They should also ask for a formal seat when fuel standards, vehicle rules and power-sector plans are appraised, and bring a health cost to the table.
Hospital chief executives run institutions that burn fuel, operate fleets and incinerate waste. Cleaning those up is modest in national terms, but it removes the obvious charge of hypocrisy and gives clinicians standing when they speak publicly.
Clinicians, especially cardiologists and neurologists, carry more authority on this topic than environmental campaigners and rarely use it. At the bedside, patients with heart disease can be told about pollution alerts the way they are told about heatwaves: stay indoors on the worst days, keep medication at hand, avoid hard exercise beside heavy traffic. At the policy table, their testimony is the one ministers find hardest to dismiss.
Payers and insurers, who carry the bills for cardiac events, have an interest in air quality that they almost never express. Funders can support the unglamorous infrastructure that makes attribution possible: local monitoring networks and linkage between pollution data and hospital records, which many low- and middle-income cities still lack.
What to watch
Over the next year or two, three signals matter. First, whether national health plans begin naming air pollution as a cardiovascular risk factor with its own targets, rather than leaving it to environment ministries. Second, whether cardiology and stroke societies treat air quality as core business in their guidelines and advocacy, not an occasional statement. Third, whether the gains in places that cleaned up are defended when economic pressure pushes the other way. Improvements that took a decade to win can be lost much faster, and the people who would notice first are on cardiac wards.
The takeaway
Air pollution’s burden is hidden because it is spread across diagnoses that already have other names. The next time a health system reports its progress on heart disease and stroke, it should ask how much of that burden was produced by the air, and who in government was responsible for it. A cardiology service that measures its success only by door-to-balloon times and statin prescriptions is managing the downstream end of a pipe whose upstream valve sits in another ministry. Treating the heart attack well matters. Asking why the ward keeps filling after every bad-air week is the part of the job the health sector has left undone for too long.
Does anyone in your health system actually own the air pollution burden? Tell us who, or whether it falls between the cracks.
